ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS)
$13.12 -0.22 (-1.6492%)
Analysed ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS) News Sources
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
09-06-2026
yahoo.com
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
12-08-2026
yahoo.com
Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
11-09-2026
yahoo.com
Eloxx Pharmaceuticals Appoints Biopharmaceutical Industry Veteran Geno Germano to its Board of Directors
19-10-2026
yahoo.com
Eloxx Pharmaceuticals Finalizes 52-Week Phase 2 EXPRESS Study Design in Nonsense-Mutation ADPKD and Appoints T.R. Srinivas, M.D., Chief Medical Officer
20-10-2026
yahoo.com
What is the current price of ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS)?
The current price of ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS) is $13.12.
ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS) since the previous trading day is $-0.22.
ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS) since the previous trading day is -1.6492%.
What is the most recent average sentiment score for ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS)?
The most recent average sentiment score for ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS) is 88 out of 100.
What is the most recent average sentiment for ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS)?
The most recent sentiment for ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS) is .
SEC-8K** Filing Available For ELOXX PHARMACEUTICALS INC (ELOX:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.